Wenhua Ling Selected Research

Adenosylhomocysteinase

1/2022	Inhibition of S-adenosylhomocysteine hydrolase induces endothelial senescence via hTERT downregulation.
1/2022	Epigenetic Upregulation of H19 and AMPK Inhibition Concurrently Contribute to S-Adenosylhomocysteine Hydrolase Deficiency-Promoted Atherosclerotic Calcification.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenhua Ling Research Topics

Disease

30	Atherosclerosis 07/2022 - 02/2008
29	Cardiovascular Diseases (Cardiovascular Disease) 02/2022 - 04/2003
22	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 08/2011
21	Inflammation (Inflammations) 07/2022 - 09/2005
20	Non-alcoholic Fatty Liver Disease 03/2022 - 05/2011
16	Insulin Resistance 01/2022 - 04/2003
10	Neoplasms (Cancer) 01/2020 - 01/2008
9	Obesity 10/2021 - 04/2011
8	Type 2 Diabetes Mellitus (MODY) 06/2021 - 10/2011
6	Atherosclerotic Plaque (Atheroma) 01/2022 - 11/2005
6	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2019
6	Body Weight (Weight, Body) 10/2021 - 06/2009
5	Fibrosis (Cirrhosis) 01/2020 - 01/2015
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2022 - 11/2012
4	Hypertension (High Blood Pressure) 10/2020 - 01/2019
4	Stroke (Strokes) 10/2020 - 11/2013
4	Thrombosis (Thrombus) 01/2020 - 01/2012
4	Fatty Liver 01/2019 - 01/2015
3	Prediabetic State (Prediabetes) 06/2021 - 10/2017
3	Infections 01/2021 - 08/2003
3	Hyperglycemia 01/2020 - 09/2012
3	Liver Cirrhosis (Hepatic Cirrhosis) 05/2019 - 01/2017
3	Hypercholesterolemia 11/2014 - 07/2010
3	Hyperlipidemias (Hyperlipidemia) 09/2012 - 03/2007
2	Dysbiosis 11/2022 - 10/2020
2	Herpes Zoster 11/2022 - 10/2020
2	Necrosis 08/2022 - 10/2020
2	COVID-19 03/2021 - 01/2021
2	Metabolic Diseases (Metabolic Disease) 01/2021 - 03/2018
2	Coronary Disease (Coronary Heart Disease) 10/2018 - 01/2007
2	Overweight 10/2018 - 01/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 01/2015

Drug/Important Bio-Agent (IBA)

30	Anthocyanins (Anthocyanin)IBA 07/2022 - 08/2006
17	LipidsIBA 01/2022 - 04/2003
15	CholesterolIBA 01/2022 - 11/2005
13	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 05/2011
12	Apolipoproteins E (ApoE)IBA 07/2022 - 02/2008
12	ApolipoproteinsIBA 02/2022 - 08/2006
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2006
10	Triglycerides (Triacylglycerol)IBA 10/2021 - 04/2011
9	S-AdenosylhomocysteineIBA 03/2022 - 02/2008
9	HomocysteineIBA 03/2022 - 02/2008
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2003
7	AntioxidantsIBA 01/2019 - 04/2003
6	coenzyme Q10 (CoQ10)IBA 01/2022 - 09/2014
6	protocatechuic acidIBA 01/2020 - 12/2010
5	C-Reactive ProteinIBA 08/2022 - 10/2011
5	Insulin (Novolin)FDA Link 01/2022 - 03/2007
5	FlavonoidsIBA 01/2020 - 09/2008
4	Interleukin-6 (Interleukin 6)IBA 08/2022 - 01/2013
4	Methionine (L-Methionine)FDA Link 03/2022 - 02/2008
4	PolyphenolsIBA 01/2022 - 12/2010
4	fibroblast growth factor 21IBA 10/2021 - 12/2016
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 11/2005
3	LipopolysaccharidesIBA 11/2022 - 10/2013
3	ChemokinesIBA 07/2022 - 01/2015
3	Complement Factor D (Factor D)IBA 01/2022 - 01/2019
3	InflammasomesIBA 01/2022 - 04/2012
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
3	AdipokinesIBA 01/2022 - 09/2018
3	CytokinesIBA 01/2021 - 11/2012
3	Vitamin A (Retinol)FDA LinkGeneric 01/2020 - 01/2017
3	25-hydroxyvitamin DIBA 10/2019 - 01/2018
3	LDL CholesterolIBA 02/2019 - 06/2009
3	Biological ProductsIBA 07/2018 - 01/2008
3	Ethanol (Ethyl Alcohol)IBA 01/2018 - 12/2012
2	OccludinIBA 11/2022 - 10/2020
2	bisphenol AIBA 11/2022 - 10/2020
2	Tight Junction ProteinsIBA 11/2022 - 10/2020
2	Toll-Like Receptor 4IBA 11/2022 - 10/2020
2	S-Adenosylmethionine (Ademetionine)IBA 03/2022 - 10/2021
2	Betaine (C.B.B.)FDA Link 02/2022 - 06/2009
2	AdenosylhomocysteinaseIBA 01/2022 - 01/2022
2	Interleukin-18 (Interleukin 18)IBA 01/2022 - 10/2020
2	oxidized low density lipoproteinIBA 01/2022 - 09/2005
2	CarbonIBA 01/2022 - 10/2014
2	intybinIBA 01/2022 - 01/2021
2	CollagenIBA 08/2021 - 10/2017
2	Nicotinamide PhosphoribosyltransferaseIBA 06/2021 - 01/2019
2	Sex Hormone-Binding GlobulinIBA 01/2021 - 01/2018
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021 - 03/2018
2	CeramidesIBA 01/2021 - 12/2020
2	Blood Glucose (Blood Sugar)IBA 10/2020 - 04/2017
2	NF-kappa B (NF-kB)IBA 10/2020 - 03/2007
2	IntegrinsIBA 01/2020 - 12/2019
2	AdiponectinIBA 01/2020 - 01/2019
2	cyanidin-3-O-beta-glucopyranosideIBA 01/2020 - 10/2017
2	hydroxide ionIBA 10/2019 - 01/2018
2	nicotinamide-beta-ribosideIBA 05/2019 - 01/2018
2	Sirtuin 1IBA 05/2019 - 01/2018
2	Uric Acid (Urate)IBA 02/2019 - 01/2016
2	Bile Acids and Salts (Bile Acids)IBA 01/2019 - 04/2012
2	ORALIT (ORS)IBA 01/2019 - 01/2017
2	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 02/2014
2	LeptinIBA 01/2019 - 11/2005
2	Choline (Choline Chloride)IBA 01/2019 - 01/2019
2	Carbon Tetrachloride (Tetrachloromethane)IBA 08/2017 - 07/2015
2	Fish OilsIBA 04/2017 - 01/2017

Therapy/Procedure

3	Therapeutics 01/2022 - 10/2011
3	Glycemic Control 01/2020 - 12/2014